Funder: National Institutes of Health
Due Dates: June 12, 2025 (New) | July 12, 2025 (Renewal/Resubmission/Revision) | September 7, 2025 (AIDS) | October 12, 2025 (New) | November 12, 2025 (Renewal/Resubmission/Revision) | January 7, 2026 (AIDS) | February 12, 2026 (New) | March 12, 2026 (Renewal/Resubmission/Revision) | May 7, 2026 (AIDS) | Additional standard NIH due dates through May 7, 2027
Funding Amounts: 3–5 years of salary support and program-related expenses; award budgets are based on salary and justified costs, not to exceed 5 years.
Summary: Supports newly independent scientists with protected time and salary to conduct basic experimental studies involving humans, enhancing their research careers.
Key Information: Applicants must propose independent basic experimental studies with humans that meet NIH's clinical trial and basic research definitions; prior consultation with NIH IC staff is strongly encouraged.
This opportunity provides support for newly independent scientists to advance their research careers through the NIH Independent Scientist Award (K02). The award is specifically for basic experimental studies involving humans—prospective studies that assign human participants to conditions and assess biomedical or behavioral outcomes to understand fundamental phenomena, without a specific application toward products or processes.
The K02 award offers three to five years of salary support and protected research time, allowing recipients to focus intensively on research and career development. Each award is tailored to the candidate's needs and must align with the scientific missions of one or more participating NIH Institutes or Centers (ICs).
Applicants must propose independent clinical trials that also meet the definition of basic research. Those not planning an independent clinical trial or proposing to gain experience in a trial led by another investigator should apply to the companion "Clinical Trial Not Allowed" opportunity.
All applications are due by 5:00 PM local time of the applicant organization. The final closing date is May 7, 2027.
Eligible Organizations:
Ineligible: Non-U.S. entities and non-U.S. components of U.S. organizations (foreign components as defined by NIH are allowed).
Eligible Individuals:
Note: Multiple PDs/PIs are not allowed. Applicants should consult the IC-specific requirements to ensure eligibility.
Topic | Contact/Resource |
---|---|
General Grants Info | GrantsInfo@nih.gov | 301-637-3015 |
eRA Commons/ASSIST | eRA Service Desk | 301-402-7469 or 866-504-9552 |
Grants.gov Support | support@grants.gov | 800-518-4726 |
IC-Specific Contacts | Table of IC-Specific Information, Requirements, and Staff Contacts |